Wegovy vs Saxenda: Comparing Two FDA-Approved Weight Loss Medications

If you're exploring prescription weight loss options, you've likely come across both Wegovy and Saxenda. Both are FDA-approved GLP-1 receptor agonists that can help with weight management, but they're not identical twins. They use different active ingredients, require different dosing schedules, and show different results in clinical studies. Let's break down what sets them apart so you can have an informed conversation with your healthcare provider.

What Are Wegovy and Saxenda?

Both Wegovy and Saxenda belong to a class of medications called GLP-1 receptor agonists. These drugs mimic a natural hormone in your body that regulates appetite and blood sugar levels.

Wegovy contains semaglutide, the same active ingredient found in Ozempic (which is FDA-approved for type 2 diabetes). It was specifically approved by the FDA for chronic weight management in 2021.

Saxenda contains liraglutide, which is also found in Victoza, another diabetes medication. Saxenda received FDA approval for weight loss back in 2014, making it the older option of the two.

Both medications are administered through weekly or daily injections that you give yourself at home, typically in the abdomen, thigh, or upper arm.

How They Work in Your Body

While both medications are GLP-1 agonists, they interact with your body slightly differently.

Wegovy (semaglutide) has a longer half-life, which means it stays active in your system longer. This is why you only need to inject it once weekly. It works by slowing down how quickly your stomach empties, reducing appetite, and helping you feel fuller for longer periods.

Saxenda (liraglutide) has a shorter duration of action, requiring daily injections. It works through similar mechanisms but leaves your system more quickly, which is why daily dosing is necessary to maintain its effects.

Both medications also influence areas of the brain involved in appetite regulation, which is a key reason they're effective for weight loss beyond just feeling physically full.

Effectiveness: What the Research Shows

When comparing weight loss results, Wegovy generally shows higher average weight loss in clinical trials.

In the STEP clinical trial program, people taking Wegovy lost an average of 15% of their body weight over 68 weeks. Some participants lost even more, with about one-third losing 20% or more of their starting weight.

Saxenda clinical trials showed an average weight loss of about 8% of body weight over 56 weeks. While this is less than Wegovy, it's still clinically significant and can lead to meaningful health improvements.

It's worth noting that individual results vary considerably. Your lifestyle, starting weight, adherence to the medication, and other health factors all influence how much weight you'll lose on either medication.

Gender Differences in Response

Research suggests that women and men may experience GLP-1 medications somewhat differently. Women often report stronger appetite suppression effects, while men may see slightly faster initial weight loss due to higher baseline metabolic rates. However, both genders achieve significant, clinically meaningful weight loss with either medication. Your individual response matters more than gender-based averages when choosing between these options.

Dosing and Administration

The dosing schedules differ significantly between these two medications.

Wegovy starts at 0.25 mg once weekly and gradually increases over several months to a maintenance dose of 2.4 mg weekly. This slow escalation helps minimize side effects as your body adjusts.

Saxenda begins at 0.6 mg daily and increases over five weeks to a maintenance dose of 3.0 mg daily. You'll need to remember to inject it every day, preferably around the same time.

For many people, the once-weekly injection of Wegovy is more convenient and easier to remember than daily Saxenda injections. However, some people prefer the daily routine or appreciate that Saxenda's shorter action time means side effects don't last as long if they occur.

Side Effects and Tolerability

Both medications share similar potential side effects since they work through the same biological pathway.

The most common side effects include nausea, diarrhea, constipation, vomiting, and abdominal pain. These are typically most noticeable when starting the medication or increasing the dose.

Because Wegovy stays in your system longer, some people find that side effects are more persistent. With Saxenda's daily dosing and shorter half-life, side effects may come and go more quickly.

Most side effects improve over time as your body adjusts. Starting with a low dose and increasing gradually helps minimize these issues. Eating smaller meals, avoiding fatty foods, and staying hydrated can also help manage digestive symptoms.

Serious side effects are rare but can include pancreatitis, gallbladder problems, and kidney issues. Both medications carry a warning about thyroid tumors based on animal studies, though this hasn't been confirmed in humans.

Cost and Insurance Coverage

Both Wegovy and Saxenda can be expensive without insurance coverage.

List prices for both medications typically range from $1,300 to $1,500 per month, though this varies by pharmacy and location. Insurance coverage has been improving for weight loss medications, but many plans still don't cover them or require significant prior authorization.

Some people turn to compounded semaglutide as a more affordable alternative to brand-name Wegovy. Compounded versions contain the same active ingredient but are prepared by specialized pharmacies and typically cost significantly less.

Manufacturer savings programs may be available for both medications if you meet certain criteria, potentially reducing your out-of-pocket costs.

Which One Is Right for You?

The choice between Wegovy and Saxenda depends on several personal factors.

Wegovy may be the better choice if you want maximum weight loss results, prefer once-weekly dosing, and can tolerate the potentially longer-lasting side effects.

Saxenda might be preferable if you want an established medication with a longer track record, don't mind daily injections, or prefer that side effects clear your system more quickly.

Your medical history matters too. If you have certain conditions or take specific medications, one option may be safer or more effective than the other. Your doctor can help evaluate these factors.

Some insurance plans cover one medication but not the other, which may influence your decision from a practical standpoint.

From the Ozari Care Team

When starting any GLP-1 medication, give your body time to adjust and don't expect perfection from day one. We typically see the best results in patients who pair their medication with sustainable lifestyle changes like adding more protein to meals and incorporating regular movement they actually enjoy. Remember that gradual progress is still progress, and consistency matters more than intensity.

At Ozari Health we offer compounded Semaglutide and Tirzepatide as low as $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026